Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)

Brief description of study

This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation using human leukocyte antigen-mismatched unrelated donors for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Blood Transplant Marrow TransplantLeukemiaLymphoma
Age: Between 18 Years - 65 Years
Gender: All

Age 1-66 Diagnosis of Leukemia

Updated on 09 Mar 2024. Study ID: 849440

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).